What is the point of the situation in breast cancer screening in Europe? Are there official screening recommendations in every country? Are there financial incentives related to this screening? Are we giving the correct information about harms and benefits of this screening to European women?

Rosália Páscoa and Emmily Schaubroeck collected these data on behalf of EUROPREV network.

Until now, we have data from seventeen countries, but we will continue to update this information set.

You may consult detailed information about each country by following the hyperlink:

Belgium  |  Croatia  |  Czech Republic  |  Denmark  |  France  |  Germany  |  Israel  |  Ireland  |  Italy  |  Poland  |  Portugal  |  Romania  |  Slovenia  |  Spain  |  Netherlands  |  Ukraine  |  United Kingdom